Ziyi Fu
Overview
Explore the profile of Ziyi Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Luo C, Li W, Li J, Fu Z, Hu N, Yu Z, et al.
Nano Lett
. 2025 Mar;
PMID: 40042082
Exciton polaritons formed by the strong coupling between excitons and photons have been extensively studied in transition metal disulfides (TMDs) for their potential to inherit ultralong radiation lifetime and remarkable...
2.
He J, Fu Z, Zou B, Lei X, Lei L, Yang Q, et al.
J Cell Mol Med
. 2025 Jan;
29(2):e70360.
PMID: 39855898
Cellular senescence is a key promoter of tumorigenesis and malignant progression. This study aimed to develop a predictive model for assessing cellular senescence in gastric cancer (GC) outcomes. We identified...
3.
Chang W, Li J, Luo C, Guo Z, Cao S, Fu Z, et al.
Opt Lett
. 2025 Jan;
50(2):630-633.
PMID: 39815579
Lithium niobate (LiNbO) has shown great potential for applications in nonlinear metasurfaces, thanks to its large second-order nonlinear coefficients and high integration capabilities. Optical resonances play a crucial role in...
4.
Xing F, Ma X, Sun B, Wang T, Lian F, Wang L, et al.
Environ Res
. 2025 Jan;
268:120806.
PMID: 39798656
Iron-loaded diatomite (Fe-DE) was developed as the innovative material to enhance anammox granular sludge (AnGS) and mainstream anammox performance. By adding Fe-DE with the Fe:DE ratio of 1:20 and the...
5.
Dai Y, Zhao S, Chen H, Yu W, Fu Z, Cui Y, et al.
Mol Biol Rep
. 2024 Nov;
52(1):27.
PMID: 39611867
Breast cancer remains the most commonly diagnosed cancer in female worldwide, marked by its molecular diversity and complex subtypes. Despite progress in targeted therapies, tumor heterogeneity and treatment resistance continue...
6.
He Y, Liu Y, Gong J, Yang F, Sun C, Yan X, et al.
Int J Biol Sci
. 2024 Aug;
20(10):3923-3941.
PMID: 39113695
About 20% of breast cancer patients are positive for HER2. The efficacy of current treatments is limited by primary and secondary resistance to trastuzumab. tRNA-derived fragments (tRFs) have shown crucial...
7.
Wang Z, Li H, Maskey A, Srivastava K, Liu C, Yang N, et al.
J Inflamm Res
. 2024 Apr;
17:2547-2561.
PMID: 38686360
Introduction: Neutrophil predominant airway inflammation is associated with severe and steroid-resistant asthma clusters. Previously, we reported efficacy of ASHMI, a three-herb TCM asthma formula in a steroid-resistant neutrophil-dominant murine asthma...
8.
Jing X, Zhou L, Ma Y, Fu Z, Huang Q, Zhang Z
BMC Chem
. 2024 Apr;
18(1):86.
PMID: 38678235
As a solid energy source, CH hydrate will inevitably break down physically as the result of geological movement or exploitation. Here, the molecular dynamics method was employed to simulate the...
9.
Duan N, Hua Y, Yan X, He Y, Zeng T, Gong J, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539453
tRNA-derived fragments (tRFs) play crucial roles in cancer progression. Among them, tRF-27 has been identified as a key factor in promoting trastuzumab resistance in HER2-positive breast cancer. However, the origin...
10.
Duan N, Hua Y, Yan X, He Y, Zeng T, Gong J, et al.
Adv Sci (Weinh)
. 2024 Mar;
11(18):e2309424.
PMID: 38460162
Secondary trastuzumab resistance represents an evolutionary adaptation of HER2-positive breast cancer during anti-HER2 treatment. Most current studies have tended to prioritize HER2 and its associated signaling pathways, often overlooking broader...